Pharmacological characterization of the pseudopterosins: Novel anti- inflammatory natural products isolated from the caribbean soft coral, Pseudopterogorgia elisabethae

Life Sciences

Volumn 62, Issue 26, 1998, Pages PL401-PL407

  Mayer, Alejandro M S ^a   Jacobson, Peer B ^b   Fenical, William ^c   Jacobs, Robert S ^d   Glaser, Keith B ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesia; Anti inflammatory natural products; Eicosanoid; Macrophage; Marine natural product; Psuedopterosins

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTIINFLAMMATORY AGENT; CD11B ANTIGEN; CELL ADHESION MOLECULE; CYTOKINE; GLYCOSIDE; ICOSANOID; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOTRIENE C4; LIPOXYGENASE; NATURAL PRODUCT; PADGEM PROTEIN; PHENYLQUINONE; PHORBOL MYRISTATE; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; PSEUDOPTEROSIN A; PSEUDOPTEROSIN E; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZYMOSAN;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORAL; DOSE RESPONSE; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; RADIOIMMUNOASSAY; TOPICAL DRUG ADMINISTRATION; WRITHING TEST;

ALCYONACEA; ANIMALIA; ANTHOZOA; GORGONIA; MURINAE; PSEUDOPTEROGORGIA ELISABETHAE;

EID: 0032557396     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0024-3205(98)00229-x     Document Type: Article

References (20)

1. 1. D.W. STANLEY-SAMUELSON, Biol. Bull. 173 92-109 (1987).
2. 2. W.H. GERWICK, Biochim. Biophys. Acta 1211 243-255 (1994).
3. 3. J.C. DEFREITAS, L.A. BLANKEMEIER, AND R.S. JACOBS, Experientia 40 864-865 (1984).
4. 4. K.B. GLASER AND R.S. JACOBS, Biochem. Pharmacol. 35 449-453 (1986).
5. 5. P.B. JACOBSON, L.A. MARSHALL, A. SUNG, AND R.S. JACOBS, Biochem. Pharmacol. 39 1557-1564 (1990).
6. 6. P.B. JACOBSON AND R.S. JACOBS, J. Pharm. Exp. Ther. 262 866-873 (1992).
7. 7. P.B. JACOBSON AND R.S. JACOBS, J. Pharm. Exp. Ther. 262 874-882 (1992).
8. 8. A.M.S. MAYER, V.J. PAUL, W. FENICAL, J.N. NORRIS, M.S. DECARVALHO, AND R.S. JACOBS, Hydrobiologia 260/261 521-529 (1993).
9. 9. K.B. GLASER, M.S. DECARVALHO, R.S. JACOBS, M.R. KERNAN, AND D.J. FAULKNER, Mol. Pharmacol. 36 782-788 (1989).
10. 10. M.S. DECARVALHO AND R.S. JACOBS, Biochem. Pharmacol. 42(8) 1621-1626 (1991).
11. 11. K.B. GLASER, M.L. SUNG, Y.W. LOCK, J. BAUER, D. KUBRAK, AND A. KREFT, Bioorg. Med. Chem. Lett. 4 1873-1878 (1994).
12. 12. S.A. LOOK, W. FENICAL, R.S. JACOBS, AND J. CLARDY, Proc. Natl. Acad. Sci. (USA) 83 6238-6240 (1986).
13. 13. S.A. LOOK, W. FENICAL, G.K. MATSUMOTO, AND J. CLARDY, J. Org. Chem. 51 5140 (1986).
14. 14. V. ROUSSIS, Z. WU, AND W. FENICAL, J. Org. Chem. 55 4916-4922 (1990).
15. 15. E. LUEDKE, A.M.S. MAYER, AND R.S. JACOBS, FASEB J. 2 1109 (1988).
16. 16. A.M.S. MAYER, K.B. GLASER, AND R.S. JACOBS, J. Pharm. Exp. Ther. 244 871-878 (1988).
17. 17. P.B. JACOBSON AND D.J. SCHRIER, J. Immunol. 151 5639-5652 (1993).
18. 18. J. AUWERX, Experientia 47 22-31 (1991).
19. 19. J.M. YOUNG, B.M. WAGNER, AND D.A. SPIRES, Invest. Dermatol. 80 48-52 (1983).
20. 20. V. PUIGNERO AND J. QUERALT, Inflammation 21 431-442 (1997).